HealthSouth Corporation
Reported net (loss) income per diluted share was ($0.14) per share for the second quarter of 2009 compared to $0.47 per diluted share for the second quarter of 2008. The as reported per share amounts for the second quarter of 2009 included a non-cash charge of $48.7 million related to amounts recorded as government, class action, and related settlements, compared to an $8.6 million gain recorded for similar amounts during the second quarter of 2008. Similarly, during the second quarter of 2009, we recorded a $3.8 million loss associated with interest rate swaps that are not designated as hedges, compared to a $28.5 million gain recorded for such swaps during the second quarter of 2008.
Substantially all of the amounts recorded as government, class action, and related settlements in each period resulted from changes in the fair value of our common stock and the associated common stock warrants underlying our securities litigation settlement. The price of our common stock increased significantly from March 31, 2009 to June 30, 2009 resulting in a $48.6 million non-cash charge included in government, class action, and related settlements for the second quarter of 2009.
On an adjusted basis, income from continuing operations was $0.39 per diluted share for the second quarter of 2009, which represents a 129.4%, or $0.22 per share, improvement over the $0.17 per diluted share for the second quarter of 2008. The quarter-over-quarter increase was primarily attributable to revenue growth, lower interest expense, and effective expense management. Adjusted income from continuing operations excludes amounts associated with government, class action, and related settlements, our loss or gain on interest rate swaps, and other non-recurring items, as outlined in the attached supplemental information.
“The second quarter of 2009 was another strong quarter for HealthSouth. We achieved solid results through both continued volume growth and disciplined expense management,” said Jay Grinney, President and Chief Executive Officer of HealthSouth. “We believe the high-quality care provided by our dedicated employees continues to be the primary reason we are seeing sustained increases in the number of patients admitted to our hospitals. As a result of the strong first half and our positive outlook for the remainder of the year, we are increasing our Adjusted Consolidated EBITDA and adjusted diluted EPS guidance for 2009.”
The Company continued to deleverage its balance sheet during the second quarter of 2009. As of June 30, 2009, total debt outstanding approximated $1.7 billion, no amounts were drawn on the Company’s $400 million revolving credit facility, and total cash and cash equivalents approximated $49.8 million.
“Our debt reduction, coupled with increased Adjusted Consolidated EBITDA, is improving our capital structure by reducing our leverage ratio on both a total and senior secured basis,” said John Workman, Executive Vice President and Chief Financial Officer of HealthSouth. “We believe the improvement in our corporate credit rating by Moody’s and the change in outlook to positive by Standard & Poor’s are confirmation of our improved condition and the success of our strategic deleveraging initiatives.”
The Company continues to believe its higher Adjusted Consolidated EBITDA (see attached supplemental information), coupled with its strong cash flows from operating activities, will allow it to achieve a leverage ratio of 4.5x or below before its stated timeframe of year-end 2010. The Company also continues to believe its longer term leverage ratio goal of 3.5x to 4.0x by the end of 2012 is progressively more achievable.
2009 Guidance
As a result of its strong operating results for the first six months of 2009, the Company is increasing its previously provided guidance for 2009. Adjusted Consolidated EBITDA guidance for 2009 has been increased from a range of $342 million to $352 million to a range of $354 million to $362 million. Adjusted diluted earnings per share have been increased from a range of $0.85 to $0.90 per share to a range of $1.15 to $1.25 per share.
Other Information
The Company’s leverage ratio that is referenced in this release and elsewhere from time to time is defined in the Company’s Credit Agreement as the ratio of consolidated total debt to Adjusted Consolidated EBITDA for the trailing four quarters. Reconciliations of net income to Adjusted Consolidated EBITDA can be found in the following schedules.
On January 1, 2009, we adopted Financial Accounting Standards Board Statement No. 160, Noncontrolling Interests in Consolidated Financial Statements, an amendment of ARB No. 51. As a result, we have reclassified our noncontrolling interests (formerly known as “minority interests”) as a component of equity and now report net income and comprehensive income attributable to our noncontrolling interests separately from net income and comprehensive income attributable to HealthSouth.
The information in this press release is summarized and should be read in conjunction with the Company’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2009 (the “June 2009 Form 10-Q”), when filed, as well as the Company’s Current Report on Form 8-K filed on August 4, 2009. In addition, the Company will post supplemental slides today on its website at http://investor.healthsouth.com/ for reference during its August 5, 2009 earnings call.
The Company expects to file its second quarter 2009 Form 10-Q this week. When filed, the report can be found on the Company’s website at http://investor.healthsouth.com/ and the SEC’s website at www.sec.gov.
HealthSouth Corporation and Subsidiaries
Condensed Consolidated Statements of Operations
(Unaudited)
Three Months Ended Six Months Ended
June 30, June 30,
------------------ -----------------
2009 2008 2009 2008
---- ---- ---- ----
(As (As
Adjusted) Adjusted)
(In Millions, Except Per Share Data)
Net operating revenues $483.7 $456.6 $958.8 $920.8
------ ------ ------ ------
Operating expenses:
Salaries and benefits 239.1 234.1 473.8 464.5
Other operating expenses 67.6 63.6 134.8 132.4
General and administrative expenses 24.9 25.2 50.4 53.3
Supplies 28.7 27.7 56.2 54.9
Depreciation and amortization 17.7 17.8 35.3 47.4
Impairment of long-lived assets - 0.6 - 0.6
Occupancy costs 12.1 12.2 24.1 24.2
Provision for doubtful accounts 9.7 6.1 17.6 13.9
Loss on disposal of assets 1.3 0.8 2.3 0.4
Government, class action, and related
settlements expense 48.7 (8.6) 32.8 (45.0)
Professional fees-accounting, tax,
and legal (3.3) 5.3 1.5 8.9
---- --- --- ---
Total operating expenses 446.5 384.8 828.8 755.5
(Gain) loss on early extinguishment
of debt (1.3) 3.4 (3.1) 3.7
Interest expense and amortization
of debt discounts and fees 31.1 43.4 65.5 90.8
Other income (1.0) (1.0) (0.8) (1.7)
Loss (gain) on interest rate swaps 3.8 (28.5) 8.8 8.1
Equity in net loss (income) of
nonconsolidated affiliates 2.7 (2.7) 0.2 (5.1)
--- ----- --- ----
Income from continuing operations
before income tax (benefit) expense 1.9 57.2 59.4 69.5
Provision for income tax (benefit)
expense (0.3) 0.7 0.9 0.8
---- --- --- ---
Income from continuing operations 2.2 56.5 58.5 68.7
Income (loss) from discontinued
operations, net of tax 1.4 (4.1) (1.4) 10.1
--- ----- ----- ----
Net income 3.6 52.4 57.1 78.8
Less: Net income attributable to
noncontrolling interests (9.1) (8.3) (17.7) (14.9)
---- ----- ----- -----
Net (loss) income attributable to
HealthSouth (5.5) 44.1 39.4 63.9
Less: Convertible perpetual preferred
stock dividends (6.5) (6.5) (13.0) (13.0)
---- ----- ----- -----
Net (loss) income attributable to
common shareholders $(12.0) $37.6 $26.4 $50.9
====== ===== ===== =====
Weighted average common shares
outstanding:
Basic 87.6 79.5 87.5 79.2
==== ==== ==== ====
Diluted 101.5 93.0 101.2 92.6
===== ==== ===== ====
Basic and diluted (loss) earnings per
common share:
(Loss) income from continuing
operations attributable to
HealthSouth common shareholders $(0.15) $0.52 $0.32 $0.50
Income (loss) from discontinued
operations, net of tax, attributable
to HealthSouth common shareholders 0.01 (0.05) (0.02) 0.14
---- ----- ----- ----
Net (loss) income per share
attributable to HealthSouth common
shareholders $(0.14) $0.47 $0.30 $0.64
====== ===== ===== =====
Amounts attributable to HealthSouth:
(Loss) income from continuing
operations $(6.7) $48.3 $41.3 $52.9
Income (loss) from discontinued
operations, net of tax 1.2 (4.2) (1.9) 11.0
--- ----- ----- ----
Net (loss) income attributable to
HealthSouth $(5.5) $44.1 $39.4 $63.9
====== ===== ===== =====
HealthSouth Corporation and Subsidiaries
Condensed Consolidated Balance Sheets
(Unaudited)
June 30, December 31,
2009 2008
---- ----
(As Adjusted)
(In Millions)
Assets
Current assets:
Cash and cash equivalents $49.8 $32.2
Restricted cash 71.7 154.0
Restricted marketable securities 21.2 20.3
Accounts receivable, net of allowance for doubtful
accounts of $33.0 in 2009; $31.1 in 2008 244.4 235.8
Insurance recoveries receivable 181.8 182.8
Other current assets 59.3 57.6
---- ----
Total current assets 628.2 682.7
Property and equipment, net 671.4 673.9
Goodwill 414.7 414.7
Intangible assets, net 39.2 42.8
Investments in and advances to nonconsolidated
affiliates 27.8 36.7
Income tax refund receivable 10.5 55.9
Other long-term assets 96.6 91.5
---- ----
Total assets $1,888.4 $1,998.2
======== ========
Liabilities and Shareholders' Deficit
Current liabilities:
Current portion of long-term debt $21.8 $23.6
Accounts payable 47.8 45.6
Accrued expenses and other current liabilities 342.1 408.5
Government, class action, and related settlements 294.4 268.5
----- -----
Total current liabilities 706.1 746.2
Long-term debt, net of current portion 1,680.1 1,789.6
Other long-term liabilities 165.1 162.2
----- -----
2,551.3 2,698.0
------- -------
Commitments and contingencies
Convertible perpetual preferred stock 387.4 387.4
----- -----
Shareholders' deficit:
HealthSouth shareholders' deficit: (1,133.2) (1,169.4)
Noncontrolling interests 82.9 82.2
---- ----
Total shareholders' deficit (1,050.3) (1,087.2)
-------- ---------
Total liabilities and shareholders' deficit $1,888.4 $1,998.2
======== ========
HealthSouth Corporation and Subsidiaries
Condensed Consolidated Statements of Cash Flows
(Unaudited)
Six Months Ended June 30,
-------------------------
2009 2008
---- ----
(As Adjusted)
(In Millions)
Cash flows from operating activities:
Net income $57.1 $78.8
----- -----
Loss (income) from discontinued operations 1.4 (10.1)
--- -----
Adjustments to reconcile net income to net
cash provided by operating activities-
Provision for doubtful accounts 17.6 13.9
Provision for government, class action,
and related settlements 32.8 (45.0)
UBS Settlement proceeds, gross 100.0 -
Depreciation and amortization 35.3 47.4
Amortization of debt issue costs, debt
discounts, and fees 3.2 3.3
Loss on disposal of assets 2.3 0.4
(Gain) loss on early extinguishment of debt (3.1) 3.7
Loss on interest rate swaps 8.8 8.1
Equity in net loss (income) of
nonconsolidated affiliates 0.2 (5.1)
Distributions from nonconsolidated affiliates 3.9 6.0
Stock-based compensation 6.6 6.0
Deferred tax provision 1.9 1.4
Other 0.6 0.1
(Increase) decrease in assets-
Accounts receivable (26.2) (33.9)
Other assets (0.7) 6.2
Income tax refund receivable 45.4 9.4
Increase (decrease) in liabilities-
Accounts payable 2.2 (1.4)
Accrued fees and expenses for derivative
plaintiffs' attorneys in UBS Settlement (26.2) -
Other liabilities (18.2) (8.3)
Government, class action, and related
settlements (8.7) (7.4)
Net cash used in operating activities of
discontinued operations (7.0) (6.5)
---- ----
Total adjustments 170.7 (1.7)
----- ----
Net cash provided by operating activities 229.2 67.0
----- ----
HealthSouth Corporation and Subsidiaries
Condensed Consolidated Statements of Cash Flows (Continued)
(Unaudited)
Six Months Ended
June 30,
------------------
2009 2008
---- ----
(As Adjusted)
(In Millions)
Cash flows from investing activities:
Capital expenditures (34.8) (18.3)
Proceeds from disposal of assets 0.8 47.2
Net change in restricted cash (15.7) 17.0
Net settlements on interest rate swap (19.1) (6.6)
Net investment in interest rate swap (6.4) -
Other (1.5) (0.4)
Net cash (used in) provided by investing
activities of discontinued operations (1.1) 0.7
---- ---
Net cash (used in) provided by investing
activities (77.8) 39.6
----- ----
Cash flows from financing activities:
Checks in excess of bank balance - (5.5)
Principal payments on debt, including
pre-payments (60.9) (92.4)
Borrowings on revolving credit facility 10.0 75.0
Payments on revolving credit facility (50.0) (150.0)
Principal payments under capital lease
obligations (6.6) (6.1)
Issuance of common stock - 150.2
Dividends paid on convertible perpetual
preferred stock (13.0) (13.0)
Distributions paid to noncontrolling
interests of consolidated affiliates (15.8) (16.5)
Other 0.7 -
Net cash provided by (used in) financing
activities of discontinued operations 1.8 (2.1)
--- ----
Net cash used in financing activities (133.8) (60.4)
------- -----
Effect of exchange rate changes on cash and
cash equivalents - 0.8
--- ---
Increase in cash and cash equivalents 17.6 47.0
Cash and cash equivalents at beginning of
period 32.2 19.8
Cash and cash equivalents of divisions and
facilities held for sale at beginning of period - 0.4
Less: Cash and cash equivalents of divisions
and facilities held for sale at end of period - -
---- ----
Cash and cash equivalents at end of period $49.8 $67.2
===== =====
HealthSouth Corporation and Subsidiaries
Supplemental Non-GAAP Disclosures
Reconciliation of Net Income to Adjusted Income from Continuing
Operations and Adjusted Consolidated EBITDA (1)(4)
Three Months Ended June 30,
---------------------------
Per Per
2009 Share(2) 2008 Share(2)
---- -------- ---- --------
(As Adjusted)
(In Millions, Except per Share Data)
Net income $3.6 $0.04 $52.4 $0.66
(Income) loss from discontinued
operations, net of tax, attributable
to HealthSouth (1.2) (0.01) 4.2 0.05
Net income attributable to
noncontrolling interests (9.1) (0.10) (8.3) (0.10)
---- ----- ---- -----
(Loss) income from continuing
Operations attributable to
HealthSouth (6.7) (0.08) 48.3 0.61
Government, class action, and related
settlements 48.7 0.56 (8.6) (0.11)
Professional fees - accounting, tax,
and legal (3.3) (0.04) 5.3 0.07
Gain on early extinguishment of debt (1.3) (0.01) - -
Loss (gain) on interest rate swaps 3.8 0.04 (28.5) (0.36)
Provision for income tax (benefit)
expense (0.3) (0.00) 0.7 0.01
Estimated income tax expense (1.1) (0.01) (1.1) (0.01)
---- ----- ---- -----
Adjusted income from continuing
operations (1)(4) 39.8 0.45 16.1 0.20
Adjustment for dilution (2) (0.06) (0.03)
----- -----
Adjusted income from continuing
operations per diluted share (2)(4) $0.39 $0.17
===== =====
Estimated income tax expense 1.1 1.1
Interest expense and amortization
of debt discounts and fees 31.1 43.4
Depreciation and amortization 17.7 17.8
---- ----
89.7 78.4
Other adjustments per the Company's
Credit Agreement:
Impairment charges, including
investments 0.1 0.6
Net noncash loss on disposal of assets 1.3 0.8
Loss on early extinguishment of debt - 3.4
Compensation expense under FASB
Statement No. 123 ( R ) 2.9 2.7
--- ---
Adjusted Consolidated
EBITDA (1)(4)(5) $94.0 $85.9
===== =====
Weighted average common shares
outstanding:
Basic 87.6 79.5
==== ====
Diluted 101.5 93.0
===== ====
HealthSouth Corporation and Subsidiaries
Supplemental Non-GAAP Disclosures
Reconciliation of Net Income to Adjusted Income from Continuing Operations
and Adjusted Consolidated EBITDA (1)(4)
Six Months Ended June 30,
-------------------------
Per Per
2009 Share(2) 2008 Share(2)
---- -------- ---- --------
(As Adjusted)
(In Millions, Except per Share Data)
Net income $57.1 $0.65 $78.8 $0.99
Loss (income) from discontinued
operations, net of tax, attributable
to HealthSouth 1.9 0.02 (11.0) (0.14)
Net income attributable to
noncontrolling interests (17.7) (0.20) (14.9) (0.19)
----- ----- ----- -----
Income from continuing operations
Attributable to HealthSouth 41.3 0.47 52.9 0.67
Government, class action, and
related settlements 32.8 0.37 (45.0) (0.57)
Professional fees - accounting,
tax, and legal 1.5 0.02 8.9 0.11
Gain on early extinguishment of debt (3.1) (0.04) - -
Loss on interest rate swaps 8.8 0.10 8.1 0.10
Accelerated depreciation of
corporate campus (3) - - 10.0 0.13
Provision for income tax expense 0.9 0.01 0.8 0.01
Estimated income tax expense (2.6) (0.03) (2.6) (0.03)
---- ----- ---- -----
Adjusted income from
continuing operations (1)(4) 79.6 0.91 33.1 0.42
Adjustment for dilution (2) (0.12) (0.06)
----- -----
Adjusted income from continuing
Operations per diluted
share (2)(4) $0.79 $0.36
===== =====
Estimated income tax expense 2.6 2.6
Interest expense and amortization
of debt discounts and fees 65.5 90.8
Depreciation and amortization,
excluding accelerated depreciation
of corporate campus (3) 35.3 37.4
---- ----
183.0 163.9
Other adjustments per the Company's
Credit Agreement:
Impairment charges, including
investments 0.8 0.6
Net noncash loss on disposal of
assets 2.3 0.6
Loss on early extinguishment of debt - 3.7
Compensation expense under FASB
Statement No. 123 ( R ) 6.6 6.0
--- ---
Adjusted Consolidated EBITDA
(1)(4)(5) $192.7 $174.8
====== ======
Weighted average common shares
outstanding:
Basic 87.5 79.2
==== ====
Diluted 101.2 92.6
===== ====
HealthSouth Corporation and Subsidiaries
Supplemental Non-GAAP Disclosures
Reconciliation of Net Income to Adjusted Income from Continuing Operations
and Adjusted Consolidated EBITDA (1)(4)
Year Ended December 31,
-----------------------
Per
2008 Share(2)
------- --------
(As Adjusted)
(In Millions, Except per Share Data)
Net income $281.8 $3.40
Income from discontinued operations, net of tax,
attributable to HealthSouth (16.9) (0.20)
Net income attributable to noncontrolling
interests (29.4) (0.35)
----- -----
Income from continuing operations attributable
to HealthSouth 235.5 2.84
Gain on UBS Settlement (121.3) (1.46)
Government, class action, and related settlements (67.2) (0.81)
Professional fees - accounting, tax, and legal 44.4 0.53
Loss on interest rate swap 55.7 0.67
Accelerated depreciation of corporate campus (3) 10.0 0.12
Interest associated with UBS Settlement (6) (9.4) (0.11)
Provision for income tax benefit (70.1) (0.84)
Estimated income tax expense (5.0) (0.06)
---- -----
Adjusted income from continuing operations (1)(4) 72.6 0.87
Adjustment for dilution (2) (0.12)
-----
Adjusted income from continuing operations
per diluted share (2)(4) $0.75
=====
Estimated income tax expense 5.0
Interest expense and amortization of debt
discounts and fees, excluding interest
associated with UBS Settlement 168.9
Depreciation and amortization, excluding
accelerated depreciation of corporate campus (3) 73.2
----
319.7
Other adjustments per the Company's Credit
Agreement:
Impairment charges, including investments 2.4
Net noncash loss on disposal of assets 2.0
Loss on early extinguishment of debt 5.9
Compensation expense under FASB Statement
No. 123 ( R ) 11.7
----
Adjusted Consolidated EBITDA (1)(4)(5) $341.7
======
Weighted average common shares outstanding:
Basic 83.0
====
Diluted 96.4
====
HealthSouth Corporation and Subsidiaries
Supplemental Non-GAAP Disclosures
Notes to Reconciliations
(1) Adjusted income from continuing operations and Adjusted Consolidated
EBITDA are non-GAAP financial measures. The Company's leverage ratio
(consolidated total debt to Adjusted Consolidated EBITDA for the trailing
four quarters) is likewise a non-GAAP financial measure. Management and
some members of the investment community utilize adjusted income from
continuing operations as a financial measure and Adjusted Consolidated
EBITDA and the leverage ratio as liquidity measures on an ongoing basis.
These measures are not recognized in accordance with GAAP and should not
be viewed as an alternative to GAAP measures of performance or liquidity.
In evaluating these adjusted measures, the reader should be aware that in
the future HealthSouth may incur expenses similar to the adjustments set
forth above.
(2) Per share amounts for each period presented are based on basic
weighted average common shares outstanding for all amounts except adjusted
income from continuing operations per diluted share, which is based on
diluted weighted average common shares outstanding. The diluted share
counts contain approximately 13.1 million shares related to the potential
dilution of the Company's convertible perpetual preferred stock. Per share
amounts do not include 5.0 million shares of common stock or warrants to
purchase approximately 8.2 million shares of common stock not yet issued
under the securities litigation settlement. The increase in the Company's
basic and diluted weighted average common shares outstanding for the three
and six months ended June 30, 2009 compared to the same periods of 2008
was primarily the result of its equity offering of 8.8 million shares that
was completed on June 27, 2008.
(3) In the first quarter of 2008, and in accordance with Financial
Accounting Standards Board Statement No. 144, Accounting for the
Impairment or Disposal of Long-Lived Assets, the Company accelerated the
depreciation of its corporate campus so that the net book value of the
campus equaled the estimated net proceeds the Company expected to receive
on the sale transaction's closing date. The year-over-year impact of this
acceleration of depreciation approximated $10 million. No similar charges
are expected in 2009.
(4) Adjusted income from continuing operations per diluted share and
Adjusted Consolidated EBITDA are two components of the Company's guidance.
(5) The Company's Credit Agreement allows unusual non-cash or non-
recurring items to be added to arrive at Adjusted Consolidated EBITDA. In
addition, certain other deductions may be required. Such amounts have not
been included in the above calculation as it would not be indicative of
the Company's Adjusted Consolidated EBITDA for future periods.
(6) Interest expense and amortization of debt discounts and fees in the
Company's consolidated statement of operations for the year ended December
31, 2008 included the reversal of approximately $9.4 million of accrued
interest related to the loan guarantee for which the Company received a
release as part of the UBS Settlement.
The Company will host an investor conference call at 9:30 a.m. Eastern Time on Wednesday, August 5, 2009 to discuss its results for the second quarter of 2009. For reference during the call, the Company will post certain supplemental slides at http://investor.healthsouth.com/.
The conference call may be accessed by dialing 8664065369 and giving the pass code 14033624. International callers should dial 9735822847 and give the same pass code. Please call approximately ten minutes before the start of the call to ensure you are connected. The conference call will also be webcast live and will be available at http://investor.healthsouth.com/ by clicking on an available link.
A replay of the conference call will be available, beginning approximately two hours after the completion of the conference call, from August 5 until August 19, 2009. To access the replay, please dial 8006421687. International callers should dial 7066459291. The webcast will also be archived for replay purposes after the live broadcast at http://investor.healthsouth.com/.
About HealthSouth
HealthSouth is the nation’s largest provider of inpatient rehabilitative healthcare services. Operating in 26 states across the country and in Puerto Rico, HealthSouth serves patients through its network of inpatient rehabilitation hospitals, long-term acute care hospitals, outpatient rehabilitation satellites, and home health agencies. HealthSouth strives to be the nation’s preeminent provider of inpatient rehabilitative healthcare services and can be found on the Web at www.healthsouth.com.
Statements contained in this press release which are not historical facts are forward-looking statements. In addition, HealthSouth, through its senior management, may from time to time make forward-looking public statements concerning the matters described herein. All such estimates, projections, and forward-looking information speak only as of the date hereof, and HealthSouth undertakes no duty to publicly update or revise such forward-looking information, whether as a result of new information, future events, or otherwise. Such forward-looking statements are necessarily estimates based upon current information and involve a number of risks and uncertainties. HealthSouth’s actual results may differ materially from the results anticipated in these forward-looking statements as a result of a variety of factors. While it is impossible to identify all such factors, factors which could cause actual results to differ materially from those estimated by HealthSouth include, but are not limited to, any adverse outcome of various lawsuits, claims, and legal or regulatory proceedings that may be brought against the Company; significant changes in HealthSouth’s management team; HealthSouth’s ability to continue to operate in the ordinary course and manage its relationships with its creditors, including its lenders, bondholders, vendors and suppliers, employees, and customers; changes, delays in (including in connection with resolution of Medicare payment reviews or appeals), or suspension of reimbursement for HealthSouth’s services by governmental or private payors; changes in the regulation of the healthcare industry at either or both of the federal and state levels; competitive pressures in the healthcare industry and HealthSouth’s response thereto; HealthSouth’s ability to obtain and retain favorable arrangements with third-party payors; HealthSouth’s ability to attract and retain nurses, therapists, and other healthcare professionals in a highly competitive environment with often severe staffing shortages and the impact on HealthSouth’s labor expenses from potential union activity and staffing shortages; general conditions in the economy and capital markets; and other factors which may be identified from time to time in HealthSouth’s SEC filings and other public announcements, including HealthSouth’s Form 10K for the year ended December 31, 2008 and Form 10-Q for the quarters ended June 30, 2009 and March 31, 2009.
Media Contact Andy Brimmer, 205-410-2777 Investor Relations Contact Mary Ann Arico, 205-969-6175maryann.arico@healthsouth.com
First Call Analyst: McVay, Tadd
FCMN Contact:
SOURCE: HealthSouth Corporation
CONTACT: Media: Andy Brimmer, +1-205-410-2777; Investor Relations: Mary
Ann Arico, +1-205-969-6175,
HealthSouth